TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scandbio AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
982,822
|
1,124,617
|
585,963 |
| Financial expenses |
3,683
|
40
|
214 |
| Earnings before taxes |
35,766
|
199,751
|
131,590 |
| EBITDA |
60,028
|
212,552
|
142,636 |
| Total assets |
646,391
|
608,169
|
590,172 |
| Current assets |
469,962
|
424,340
|
426,827 |
| Current liabilities |
229,898
|
297,434
|
190,244 |
| Equity capital |
330,662
|
297,442
|
388,568 |
| - share capital |
6,188
|
6,078
|
5,675 |
| Employees (average) |
104
|
103
|
106 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
51.2%
|
48.9%
|
65.8% |
| Turnover per employee |
9,450
|
10,919
|
5,528 |
| Profit as a percentage of turnover |
3.6%
|
17.8%
|
22.5% |
| Return on assets (ROA) |
6.1%
|
32.9%
|
22.3% |
| Current ratio |
204.4%
|
142.7%
|
224.4% |
| Return on equity (ROE) |
10.8%
|
67.2%
|
33.9% |
| Change turnover |
-162,073
|
497,076
|
-286,908 |
| Change turnover % |
-14%
|
79% | |
| Chg. No. of employees |
1
|
-3
|
-24 |
| Chg. No. of employees % |
1%
|
-3% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.